During the past decade, Seok Kyeong Oh conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Seok Kyeong Oh" are "Lumbar Spine Disease" (1 trials) and "Spine Disease" (1 trials). Many other conditions were trialed in "Seok Kyeong Oh" in a lesser frequency.

Most popular intervention types in "Seok Kyeong Oh" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Propofol" (1 trials), "Remimazolam Besylate" (1 trials), "Rocuronium for deep NMB" (1 trials) and "Rocuronium for moderate NMB" (1 trials). Other intervention names were less common.

The vast majority of trials in "Seok Kyeong Oh" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Seok Kyeong Oh". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 1 completed trials in Seok Kyeong Oh, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Seok Kyeong Oh, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".